These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 17954675)
1. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease. Keshavjee S; Gelmanova IY; Pasechnikov AD; Mishustin SP; Andreev YG; Yedilbayev A; Furin JJ; Mukherjee JS; Rich ML; Nardell EA; Farmer PE; Kim JY; Shin SS Ann N Y Acad Sci; 2008; 1136():1-11. PubMed ID: 17954675 [TBL] [Abstract][Full Text] [Related]
2. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Pablos-Mendez A; Gowda DK; Frieden TR Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008 [TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Shin SS; Pasechnikov AD; Gelmanova IY; Peremitin GG; Strelis AK; Mishustin S; Barnashov A; Karpeichik Y; Andreev YG; Golubchikova VT; Tonkel TP; Yanova GV; Nikiforov M; Yedilbayev A; Mukherjee JS; Furin JJ; Barry DJ; Farmer PE; Rich ML; Keshavjee S Int J Tuberc Lung Dis; 2006 Apr; 10(4):402-8. PubMed ID: 16602404 [TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Caminero JA Int J Tuberc Lung Dis; 2010 Apr; 14(4):382-90. PubMed ID: 20202293 [TBL] [Abstract][Full Text] [Related]
5. What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective. Tang S; Squire SB Health Policy; 2005 Apr; 72(1):93-104. PubMed ID: 15760702 [TBL] [Abstract][Full Text] [Related]
6. Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):253-6. PubMed ID: 19300407 [TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants. Atre SR; Mistry NF J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879 [TBL] [Abstract][Full Text] [Related]
8. Programmatic management of multidrug-resistant tuberculosis: models from three countries. Furin J; Bayona J; Becerra M; Farmer P; Golubkov A; Hurtado R; Joseph JK; Keshavjee S; Ponomarenko O; Rich M; Shin S Int J Tuberc Lung Dis; 2011 Oct; 15(10):1294-300. PubMed ID: 21669029 [TBL] [Abstract][Full Text] [Related]
9. Limited good and limited vision: multidrug-resistant tuberculosis and global health policy. Yong Kim J; Shakow A; Mate K; Vanderwarker C; Gupta R; Farmer P Soc Sci Med; 2005 Aug; 61(4):847-59. PubMed ID: 15896895 [TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G; J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698 [TBL] [Abstract][Full Text] [Related]
11. Time to put boots on the ground: making universal access to MDR-TB treatment a reality. Keshavjee S; Farmer PE Int J Tuberc Lung Dis; 2010 Oct; 14(10):1222-5. PubMed ID: 20843411 [No Abstract] [Full Text] [Related]
12. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics? Dubrovina I; Miskinis K; Lyepshina S; Yann Y; Hoffmann H; Zaleskis R; Nunn P; Zignol M Int J Tuberc Lung Dis; 2008 Jul; 12(7):756-62. PubMed ID: 18544200 [TBL] [Abstract][Full Text] [Related]
14. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation. Caminero JA Int J Tuberc Lung Dis; 2008 Aug; 12(8):869-77. PubMed ID: 18647445 [TBL] [Abstract][Full Text] [Related]
15. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool. Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438 [TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
17. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance. Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897 [TBL] [Abstract][Full Text] [Related]
18. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. Morozova I; Riekstina V; Sture G; Wells C; Leimane V Int J Tuberc Lung Dis; 2003 Sep; 7(9):903-6. PubMed ID: 12971677 [TBL] [Abstract][Full Text] [Related]
19. Global incidence of multidrug-resistant tuberculosis. Zignol M; Hosseini MS; Wright A; Weezenbeek CL; Nunn P; Watt CJ; Williams BG; Dye C J Infect Dis; 2006 Aug; 194(4):479-85. PubMed ID: 16845631 [TBL] [Abstract][Full Text] [Related]